Latest / Pharmacy Podcast Network / Patients Before Monopolies Act | PBM Reform Podcast
Transcript
- 0:01Speaker 1: Welcome back to the exchange.
- 0:02Speaker 2: A bipartisan group of Senators introducing a bill to break
- 0:05Speaker 2: up pharmacy benefit managers.
- 0:08Speaker 1: Bertha Coombs is here with the details.
- 0:09Speaker 2: Bertha, this has been simmering for a very very long time.
- 0:13Speaker 2: For the last couple of years have been a number
- 0:15Speaker 2: of bills introduced today. This is not just bipartisan but
- 0:18Speaker 2: by cameral. It also has members of the House who
- 0:22Speaker 2: are on this.
- 0:23Speaker 1: And the nuts and bolts of.
- 0:25Speaker 2: This are to break up the big PBMs and insurers,
- 0:29Speaker 2: although this specifically looks at the issue of them owning pharmacies.
- 0:34Speaker 2: Under the bill, which is the Patients Before Monopolies PBM Act,
- 0:38Speaker 2: it would basically prohibit a PBM or an insurer from
- 0:43Speaker 2: owning a pharmacy. The big PBMs all do right now.
- 0:47Speaker 2: They have mail order pharmaciencies that they have and of
- 0:50Speaker 2: course CVS which has CVS Caremart and Etna also has
- 0:55Speaker 2: brick and mortar pharmacies as well as the mail order.
- 0:57Speaker 1: It would require.
- 0:58Speaker 2: Those firms to divest those pharmacy businesses over three years,
- 1:03Speaker 2: and it would direct the FTC to distribute or disgorge
- 1:08Speaker 2: revenue to what they called harm communities. Now, analysts are
- 1:13Speaker 2: saying this is not likely to pass and make it
- 1:16Speaker 2: to the floor during the lame duck session here ahead
- 1:20Speaker 2: of the new administration coming in, but certainly there is
- 1:24Speaker 2: more momentum over this and this could be something that
- 1:28Speaker 2: could be renewed in the new year, given the fact
- 1:31Speaker 2: that we do have this bipartisan and by cameral agreement.
- 1:45Speaker 3: Thanks for listening to the Pharmacy Podcast Network.
- 2:08Speaker 4: Welcome to the PBM Reform Podcast, where we dive deep
- 2:12Speaker 4: into the world of pharmaceutical benefit management, cutting through the
- 2:16Speaker 4: noise to uncover the truth. Since twenty nineteen, we've been
- 2:21Speaker 4: your go to source for the latest on how PBMs
- 2:24Speaker 4: impact patient care, drug pricing, and the very future of pharmacy.
- 2:29Speaker 4: Here we champion the role of pharmacists, the most knowledgeable
- 2:33Speaker 4: advocates for medication safety and expertise. Join us as we
- 2:38Speaker 4: expose and generate discussions that are reshaping healthcare and explore
- 2:42Speaker 4: how we build a better payment system which focuses on
- 2:45Speaker 4: advancing pharmacy care.
- 2:55Speaker 3: Today is a really special episode of the PBM Reform Podcast.
- 3:00Speaker 3: We have two people who are passionate about reforming our
- 3:05Speaker 3: pharmacy benefit managers. We have Greg Ribold, who is the
- 3:10Speaker 3: Vice president of healthcare Policy and general Counsel for the
- 3:14Speaker 3: American Pharmacy Cooperative, and we have Congressmen from Massachusetts of
- 3:20Speaker 3: the fourth District, Jake Auchenclass. It's great to have you
- 3:25Speaker 3: here with all of your experience in understanding PBM reform,
- 3:29Speaker 3: working with wholesalers, working with pharmacy owners, working with different
- 3:34Speaker 3: sectors of pharmacy. This is the most important factor of
- 3:39Speaker 3: our pharmacy profession. Greg I want you to share with
- 3:43Speaker 3: our listeners what you've been working on and how things
- 3:47Speaker 3: have been going.
- 3:47Speaker 5: Oh, that's right, and you know this healthcare policy and
- 3:50Speaker 5: PBM practices in particular are ever evolving, right, and we
- 3:54Speaker 5: work hard to try to get the policy right on
- 3:57Speaker 5: behalf of our members, on behalf of you know, really
- 3:59Speaker 5: all community pharmacists, and you know the system as a whole,
- 4:02Speaker 5: and most importantly are our members patients.
- 4:06Speaker 3: Without further delay, we have a very special guest with
- 4:10Speaker 3: us today. Very proud to have this hard working politician
- 4:16Speaker 3: working for the American people, someone who really understands PBM reform.
- 4:21Speaker 3: Welcome to the PBM Reform Podcast. Congressman Jake Auchenclass from
- 4:26Speaker 3: the great state of Massachusetts. Thank you for having me
- 4:29Speaker 3: on Representative Auchenclass. It is wonderful to have you here.
- 4:34Speaker 3: We know that you have worked with Greg Ribold before,
- 4:38Speaker 3: so this is really nice to have the both of
- 4:40Speaker 3: you here at the same time. Just right out of
- 4:43Speaker 3: the gate, Jake, we want you to give the listeners
- 4:46Speaker 3: just an update, a little bit of information on yourself.
- 4:49Speaker 3: How hard you've been working on the PBM reform Pharmacist
- 4:52Speaker 3: fight Back bill. Take it away, Jake.
- 4:55Speaker 6: I am finishing my second term representing the Massachusetts fourth
- 4:59Speaker 6: which is thirty five cities in towns in eastern Massachusetts,
- 5:02Speaker 6: some of the inner suburbs of Boston, all the way.
- 5:05Speaker 1: Through the border of Rhode Island.
- 5:06Speaker 6: And I came into PBM reform really starting with my
- 5:10Speaker 6: first term in Congress around twenty twenty one, because I
- 5:13Speaker 6: represent a big healthcare district, a lot of biotech entrepreneurs,
- 5:18Speaker 6: a lot of public health professionals, physicians and nurses, and
- 5:21Speaker 6: medical device companies, and we were doing a significant amount
- 5:25Speaker 6: of health care work and a significant amount of drug
- 5:28Speaker 6: pricing work in particular, which I had a special interest.
- 5:31Speaker 6: And I grew up in a family of medical scientists
- 5:34Speaker 6: and both on behalf of my constituents who pay for
- 5:37Speaker 6: prescription drugs and on behalf of my constituents who are
- 5:40Speaker 6: researching and manufacturing new prescription drugs. This is an issue
- 5:43Speaker 6: that matters to Massachusetts. And as I was exploring drug
- 5:47Speaker 6: pricing policy, it's kind of like when astronomers are looking
- 5:51Speaker 6: through the telescope and they see planets moving around, but
- 5:55Speaker 6: they're wobbling and they're not moving in the way that
- 5:57Speaker 6: they should be, and they go back to the data
- 5:59Speaker 6: and they what's going on here?
- 6:02Speaker 1: It's not lining up, and they always say it's dark energy.
- 6:04Speaker 6: It's like eighty percent of the universe is dark energy,
- 6:06Speaker 6: and it's causing these perturbations and the planets and light
- 6:09Speaker 6: is moving around it and it's getting bent, etc.
- 6:12Speaker 1: And as as exploring drug pricing.
- 6:14Speaker 6: Policy, it was like there was this dark energy inside
- 6:16Speaker 6: of the pharmacoeconomics of how prescriptions are being prescribed and
- 6:21Speaker 6: dispensed and reimbursed, and I was like, what's going on here?
- 6:24Speaker 6: There's this like irrational black hole at the center of
- 6:27Speaker 6: this system. And of course that led me to pharmacy
- 6:31Speaker 6: benefit Managers. And the thing about PBMs is eighty percent
- 6:36Speaker 6: of our work with PBMs is just introducing the concept
- 6:41Speaker 6: to policy makers into Americans, because once people understand what
- 6:45Speaker 6: they are, oh, they're the middlement of drug pricing, so
- 6:48Speaker 6: much of what follows actually becomes intuitive. You don't have
- 6:51Speaker 6: to become an expert on spread pricing or dir fees
- 6:54Speaker 6: or steering policy, because so much of it is actually
- 6:57Speaker 6: just intuitive about the rent seeking and monopolist behavior that
- 7:00Speaker 6: will always that will always follow from their privileged middleman
- 7:05Speaker 6: position in a very concentrated market. And so once I
- 7:08Speaker 6: started to unpick that, I met people like Greg we
- 7:11Speaker 6: dug In, and we realized that if we're really going
- 7:15Speaker 6: to get drug pricing right for Americans, right in a
- 7:17Speaker 6: way that leads to more cures, faster, right in a
- 7:20Speaker 6: way that leads the lower out of pocket costs, right
- 7:22Speaker 6: in a way that lowers premiums and stops the price gouging,
- 7:26Speaker 6: right in a way that empowers community pharmacists to be
- 7:29Speaker 6: small business owners and medical providers.
- 7:31Speaker 1: If we're going to get all that right, we need.
- 7:34Speaker 6: To start by raining in the malfeasance, the greed, the
- 7:39Speaker 6: abuse of these big three pharmacy benefit managers.
- 7:41Speaker 1: And that's what we're doing.
- 7:44Speaker 3: Thank you for that, Jake, Greg. I want to turn
- 7:46Speaker 3: back to you. I want to understand what is happening
- 7:51Speaker 3: right now that's making the difference. Why do we see
- 7:55Speaker 3: both sides of the aisle jumping on the Pharmacists Fight
- 7:58Speaker 3: Back Act and pushing for this. We have a unity,
- 8:02Speaker 3: we have fifty three signed sponsors. What is it about this?
- 8:07Speaker 3: What's is it? The timing is that the bill? Is
- 8:10Speaker 3: it the language? Why are we having what seems like
- 8:14Speaker 3: the success that we've been waiting for?
- 8:17Speaker 5: You know, listen, I think there's I think there's a
- 8:19Speaker 5: lot of reasons, right, And obviously PPM reform has evolved
- 8:23Speaker 5: in a number of ways, but Pharmacists fight Back at
- 8:26Speaker 5: HR ninety ninety six at the federal level, you know,
- 8:29Speaker 5: from my perspective, really represents a quantum leap, and I
- 8:32Speaker 5: think it's resonated.
- 8:33Speaker 1: Right.
- 8:33Speaker 5: We were at a time where in the last two
- 8:35Speaker 5: years there are so many drug pricing bills, so many,
- 8:39Speaker 5: so many PBM bills that have been introduced, and some
- 8:42Speaker 5: of them really really good, you know, no question about that.
- 8:46Speaker 5: But yet I feel like as big as the problem is,
- 8:49Speaker 5: and you can't walk talk about drug pricing with walking
- 8:52Speaker 5: right smack into PBM practices. As big as PBMs are
- 8:56Speaker 5: and as large as the problem is there was sort of,
- 9:00Speaker 5: I would say, almost an appetite to nibble around the
- 9:02Speaker 5: edges of these practices right light transparency, reporting, working in
- 9:06Speaker 5: narrow markets, and really in many ways making small steps.
- 9:12Speaker 5: And what the Pharmacist Right Back Act really looks to
- 9:14Speaker 5: do is and all credit to Congress and Auking Class here, right,
- 9:18Speaker 5: because he's the one who's willing to take this sort
- 9:20Speaker 5: of quantum step. And it turns out that his instincts
- 9:23Speaker 5: were right, and it's resonated because these practices taste bad
- 9:27Speaker 5: to folks who aren't necessarily drug pricing experts, and so
- 9:31Speaker 5: it's resonated in a way. You know, Congressman Aucking Class
- 9:34Speaker 5: called for I think fifty fifty people on the bill
- 9:36Speaker 5: by Thanksgiving and hit that and I think we're about
- 9:39Speaker 5: fifty six all in right now. But what this bill
- 9:43Speaker 5: looks to do is really say no more. And it
- 9:45Speaker 5: looks to sort of take the bad pat practices that
- 9:48Speaker 5: PBMs stand on, which is drug pricing, manipulation, rebate manipulation,
- 9:53Speaker 5: patient steering, and it looks to stop those practices. It
- 9:58Speaker 5: looks to end the practices the PBMs used to drive
- 10:01Speaker 5: prices up and restrict patient choice.
- 10:04Speaker 3: Jake, what got you so interested in PBUM reform. As
- 10:08Speaker 3: a state representative, your main focus is to be on
- 10:14Speaker 3: the constituents, the citizens of the great State of Massachusetts
- 10:18Speaker 3: in your district. However, your voice is resonating on a
- 10:22Speaker 3: national level now and now you're involved with the Pharmacists
- 10:26Speaker 3: Fight Backed Act. But where did it start? Obviously starting
- 10:29Speaker 3: in Massachusetts. Give our listeners a little a little backtrack
- 10:35Speaker 3: as to how this all started specifically to your state.
- 10:39Speaker 6: What's happening in Massachusetts is a microcosm of what's happening
- 10:41Speaker 6: everywhere in the country, which is one we're seeing independent
- 10:44Speaker 6: pharmacists under unrelenting pressure. Both back of store and front
- 10:48Speaker 6: of store are different forces at work there, but in
- 10:50Speaker 6: the back of the store, they're being reimbursed by their competitors.
- 10:55Speaker 6: And I don't care how good of a small business
- 10:57Speaker 6: owner you are, I don't care how sadly you are.
- 10:59Speaker 6: It just becomes is untenable when your margin is being
- 11:02Speaker 6: decided by your competitor. And ohps, your competitors a Fortune
- 11:06Speaker 6: twenty company and you're a main street business. And so
- 11:09Speaker 6: I was seeing that, I am seeing that up close
- 11:11Speaker 6: and personal. I've been able to visit independent pharmacists throughout
- 11:15Speaker 6: my district across the thirty five cities and towns I represent,
- 11:19Speaker 6: and invariably the people I talked to are really critical
- 11:24Speaker 6: parts of their communities. They are, you know, hubs of
- 11:28Speaker 6: their downtowns who draw in foot traffic and vehicular traffic.
- 11:32Speaker 6: Then most people then go on and buy a coffee
- 11:34Speaker 6: and go to the grocery store and grab a bite
- 11:36Speaker 6: to eat, so they create a lot of value for
- 11:38Speaker 6: their downtowns. There are, of course, medical providers and trusted
- 11:41Speaker 6: medical providers and the most accessible medical providers for most Americans,
- 11:45Speaker 6: particularly in rural America.
- 11:47Speaker 1: And then third, they're small business owners.
- 11:49Speaker 6: They're trying to balance the credits and the debts in
- 11:52Speaker 6: a way that you know, feels very visceral for their neighbors.
- 11:56Speaker 6: And so I've been able to partner with and communicate
- 11:59Speaker 6: with the pharmacists in my district to explain why what
- 12:02Speaker 6: can feel like very wonky drug pricing policy in Washington,
- 12:05Speaker 6: DC directly matters to my constituents.
- 12:08Speaker 1: It matters about your copay at the pharmacy counter.
- 12:10Speaker 6: It matters about the premium you're paying, particularly if you're
- 12:12Speaker 6: an employer sponsored health care insurance. And it matters about
- 12:16Speaker 6: your community. It matters every one of us. I think
- 12:20Speaker 6: can picture you walk through a downtown and you see
- 12:23Speaker 6: a boarded up storefront, a lot of times those of pharmacies.
- 12:27Speaker 6: It certainly is in my downtown where I live. That's
- 12:29Speaker 6: bad for our communities.
- 12:32Speaker 1: If I could.
- 12:33Speaker 5: Just kind of capitalize on that, right, you know, Congressman
- 12:36Speaker 5: Auking class represents really one of the most sophisticated medical
- 12:41Speaker 5: hubs medical communities in the world right when you think
- 12:45Speaker 5: of just sort of the cross section of his district
- 12:47Speaker 5: and the work that gets done there and so, you know,
- 12:50Speaker 5: and obviously with the background with family members who are
- 12:53Speaker 5: you know, medical scientists, doctors, and so, you know, to
- 12:57Speaker 5: have him recognize the role that pharmacies play in the
- 13:01Speaker 5: healthcare system across the country and on main streets and
- 13:05Speaker 5: their accessibility and particularly the role that they play, you know,
- 13:08Speaker 5: in rural America. What a powerful voice to make that point.
- 13:13Speaker 1: Well, they're going to need more support.
- 13:14Speaker 6: To you, Greg, I appreciate that, And I guess the
- 13:18Speaker 6: way I view it in my head is they need
- 13:21Speaker 6: both front of store and back of store support right now.
- 13:24Speaker 6: And so the back of store support, A big part
- 13:26Speaker 6: of that is the is the legislation so that the
- 13:29Speaker 6: PBMs have to be neutral arbiters and just you know,
- 13:33Speaker 6: basically use using that act plus and where we are
- 13:36Speaker 6: reimbursing pharmacists based on the quality of the service they
- 13:39Speaker 6: are providing as opposed to them getting put underwater by
- 13:43Speaker 6: their competitors.
- 13:44Speaker 1: But they also need fun of store support.
- 13:46Speaker 6: Some of that's going to be state level policy, but
- 13:48Speaker 6: allowing them to expand their scope of practice. I've talked
- 13:51Speaker 6: to pharmacists in my district who are providing optical services,
- 13:55Speaker 6: who are doing vaccines and diagnostics, and as medical devices
- 13:58Speaker 6: become more sophisticated, as we're able to do more outpatient
- 14:02Speaker 6: care at a high quality, I think that's an enormous
- 14:05Speaker 6: opportunity for pharmacists to expand.
- 14:07Speaker 1: Their portfolio that they offer and.
- 14:10Speaker 6: To expand their revenue streams, make their businesses more diversified
- 14:14Speaker 6: and resilient, and also make them even more useful and
- 14:17Speaker 6: engaged with their neighbors and their patients. This is a
- 14:20Speaker 6: net plus for American healthcare because we have a massive
- 14:23Speaker 6: deficit of primary care physicians right now in nurse practitioners,
- 14:27Speaker 6: we need more frontline medical providers who can do the
- 14:30Speaker 6: full suite of preventative and Primary Care.
- 14:33Speaker 3: PBMs were never ever supposed to become what they are today.
- 14:39Speaker 3: They were supposed to be simplistic administrative abilities to manage
- 14:45Speaker 3: formula ares, help big employers with the organization of met access,
- 14:52Speaker 3: and it was never supposed to have the control that
- 14:56Speaker 3: the three big PBMs do today. And it's it's run.
- 15:00Speaker 3: It's out of control. You know it. We know it.
- 15:03Speaker 3: Greg knows it. The listeners, the primary listeners know it.
- 15:07Speaker 3: If you don't understand PBMs, there's so much information out there.
- 15:12Speaker 3: We have a podcast podcast you're listening to right now.
- 15:16Speaker 3: We've been publishing this since twenty nineteen. It's changed since
- 15:20Speaker 3: twenty nineteen. But PBMs are not supposed to be what
- 15:25Speaker 3: they are standing in right now. The way that they
- 15:28Speaker 3: are doing business today is anti healthcare and it's anti
- 15:34Speaker 3: public health. And that's why Jake is so concerned as
- 15:39Speaker 3: state representative, and that's why this bill is so vitally important.
- 15:45Speaker 1: This is the point I oftentimes make.
- 15:47Speaker 6: In fact, I said this at a recent bipartisan press
- 15:49Speaker 6: conference we had, is you know, when PBMs were first incepted,
- 15:54Speaker 6: they performed a necessary function. Somebody's got to say no
- 15:58Speaker 6: to the big pharmaceutical manufacturers say, you know, you got
- 16:00Speaker 6: to do a generic not a brand name drug. Somebody's
- 16:02Speaker 6: going to manage the formulary, somebody's got to do the reimbursements.
- 16:05Speaker 1: There is this like.
- 16:06Speaker 6: Back end sort of paper shuffling function that needs to
- 16:09Speaker 6: get done. But the problem is is that they got greedy.
- 16:13Speaker 1: Right. They realized that there was a lot of money
- 16:15Speaker 1: crossing their transom.
- 16:17Speaker 6: They realized how opaque the supply chain was, they realized
- 16:20Speaker 6: how concentrated they were, they realized how much at the
- 16:22Speaker 6: gate they were standing, and they got greedy. And now
- 16:25Speaker 6: they need to be rained in and they need to
- 16:27Speaker 6: be returned back to a technocratic service function with a
- 16:30Speaker 6: flat rate fee.
- 16:32Speaker 3: Jake, it's refreshing as someone in Congress that understands that
- 16:36Speaker 3: Greg super excited current events. We know that there's another
- 16:41Speaker 3: bill that's being proposed Jake Achincloss as part of this,
- 16:46Speaker 3: so we're going to definitely ask for his feedback. But
- 16:49Speaker 3: it would prevent insurance companies from owning pharmacies. Now that's
- 16:54Speaker 3: a duh moment for me, like, oh duh, Like why
- 16:57Speaker 3: would you ever want your insurance company to own a
- 17:02Speaker 3: pharmacy in order to divert business from independence or other
- 17:07Speaker 3: chain pharmacies or other patient choice choosing whatever pharmacy that
- 17:11Speaker 3: they want. To push it back to the inefficiencies of
- 17:16Speaker 3: these giant mail order pharmacies that just stamp out prescriptions.
- 17:22Speaker 3: Then nothing more than a money machine, has nothing to
- 17:24Speaker 3: do with healthcare. Bring us up to date on that, Greg.
- 17:28Speaker 5: Yes and Conisonacahaus, please feel free to jump in because
- 17:31Speaker 5: I know you're you're a major part of this, right.
- 17:33Speaker 5: But so news came out this week about the Patients
- 17:36Speaker 5: Before Monopolies Act, which would essentially say, hey, if you're
- 17:39Speaker 5: if you're a corporation, you can't own an insure in
- 17:42Speaker 5: PBM and own a pharmacy with a broad definition of pharmacy.
- 17:47Speaker 5: So whether it's a pharmacy with a retail footprint, a
- 17:50Speaker 5: mail order footprint, especially footprint, you can't play in both pools, right,
- 17:54Speaker 5: and it would ultimately require divestiture. So really big deal.
- 17:58Speaker 5: And Todd glad you mentioned in Stark law, right because
- 18:03Speaker 5: healthcare attorney here right in compliance healthcare attorney for a
- 18:05Speaker 5: long time. And if you're a healthcare provider in this nation,
- 18:10Speaker 5: there are laws that protect against self interested transactions, right,
- 18:14Speaker 5: there are laws that prohibit, you know, sometimes maybe even
- 18:17Speaker 5: to too many extremes. But there are laws that prohibit
- 18:20Speaker 5: physicians from having any kind of a self interested referral whatsoever.
- 18:24Speaker 5: Right so a physician a clinic, referring to a diagnostic
- 18:27Speaker 5: lab or whatever the case may be. And there are
- 18:30Speaker 5: these anti kickback laws which prohibit offering remuneration to get
- 18:34Speaker 5: reimbursed under a federal health care program. And what we
- 18:37Speaker 5: have today is the largest companies on earth, these PBMs
- 18:40Speaker 5: and insures own pharmacies and they are steering patients into
- 18:45Speaker 5: their channels on the grandest scale that we have ever
- 18:49Speaker 5: seen in healthcare. So a main street physician, you know,
- 18:52Speaker 5: can quickly run a foul of criminal laws and incur
- 18:55Speaker 5: criminal liability for self referring to something down the street
- 18:59Speaker 5: if that phs isn't complying with certain safe harbors. But
- 19:02Speaker 5: yet you've got the largest insurres and PBMs on earth
- 19:06Speaker 5: that are just on a massive scale steering into their
- 19:10Speaker 5: channels and they're targeting some of the sickest patients in
- 19:13Speaker 5: the country to do it. And Congressman Ochyclaus has done
- 19:16Speaker 5: amazing work highlighting some of these markups and what this
- 19:20Speaker 5: vertical integration and what this self interested steering has really
- 19:24Speaker 5: led to from a patient drug pricing perspective.
- 19:28Speaker 3: All right, so, Jake, what about the Patients Before Monopolies Act?
- 19:33Speaker 3: Can you elaborate on that and bring us up to date.
- 19:36Speaker 6: This is bipartisan, it's bi cameral. We just introduced it
- 19:39Speaker 6: this week. I'm the lead of it in the House.
- 19:41Speaker 6: Senator Warren and Senator Holly are the lead in the Senate.
- 19:44Speaker 6: I'm working on it with Diana Harshbarger, who's been my
- 19:46Speaker 6: partner on the Pharmacist Fight Back Act as well. So
- 19:48Speaker 6: we're getting the band back together for this bill. And
- 19:52Speaker 6: to me, this is a step towards what is a
- 19:56Speaker 6: broader mission, which is within the pharmaceuticals apply chain. We've
- 20:00Speaker 6: got to separate the medicine from the money. There needs
- 20:03Speaker 6: to be a firewall where if you are researching a drug,
- 20:08Speaker 6: manufacturing a drug, prescribing a drug, shipping a drug, dispensing
- 20:13Speaker 6: a drug, you're on one side. And then if you
- 20:15Speaker 6: are managing the claims, the formulary, if you're a broker,
- 20:19Speaker 6: if you are doing reimbursement or analysis anything on this
- 20:23Speaker 6: sort of the money side, you're on the other side
- 20:25Speaker 6: of the firewall, and those two functions should not be
- 20:27Speaker 6: under the same corporate roof, because otherwise you get CBS
- 20:32Speaker 6: care Mark a unted health group, where you just get massive,
- 20:36Speaker 6: at scale stark law violations. As Greg I think very
- 20:40Speaker 6: eloquently put it, the temptation to self deal is overwhelming,
- 20:45Speaker 6: and I would actually argue is irresistible when you consider
- 20:48Speaker 6: that they would have a fiduciary standard to maximize their
- 20:52Speaker 6: vertical integration to their shareholders. So we have to just
- 20:56Speaker 6: force the divestment and force and force the deconfliction of
- 20:59Speaker 6: the inn. And there's precedent for this in a very
- 21:02Speaker 6: different realm, which is in financial services. So in the
- 21:05Speaker 6: nineteen thirties we passed the Glass Steagel Law, and the
- 21:09Speaker 6: Glass Steagle said to banks, hey, listen, you can invest money, right,
- 21:13Speaker 6: you can go out there and speculate, or you can
- 21:14Speaker 6: hold customer money, but you cannot take customer money and
- 21:17Speaker 6: then go out.
- 21:18Speaker 1: And speculate with it. And that was a good idea.
- 21:21Speaker 6: It turned out that was a good idea because there
- 21:24Speaker 6: needed to be basically this demarcation of interest where you're
- 21:26Speaker 6: doing one thing or you're doing the other thing, but
- 21:28Speaker 6: never the twain shall meet. We got to do a
- 21:30Speaker 6: glass steagel for the pharmaceutical supply chain, and this bill
- 21:33Speaker 6: is the first Jake.
- 21:34Speaker 3: It's so important for our community, for pharmacy owners, for patients.
- 21:41Speaker 3: Maybe we can educate patients to keep things going. The
- 21:45Speaker 3: momentum of the Patients Before Monopolies Act is going to
- 21:50Speaker 3: come right after the Pharmacists Fights Back Act, which is amazing.
- 21:54Speaker 3: But from your advice to the listener, what should they
- 21:58Speaker 3: be doing? Is there anything else else that can be
- 22:00Speaker 3: done to keep the momentum going on on these new bills?
- 22:05Speaker 6: Engagement matters. I will tell you this legislation. I set
- 22:09Speaker 6: the goal of fifty co sponsors by Thanksgiving when we
- 22:12Speaker 6: introduced it late in the summer, and that was a
- 22:14Speaker 6: stretch goal, to be candid with you, I mean, we
- 22:16Speaker 6: were out of session for a number of weeks because
- 22:18Speaker 6: of the election, right obviously, right during campaign season. It's
- 22:21Speaker 6: a tough time to build out bipartisan support for a
- 22:24Speaker 6: piece of complicated legislation. So it was a stretch goal.
- 22:27Speaker 6: And as Greg said, we got We beat it. We
- 22:29Speaker 6: beat fifty by Thanksgiving. And that was not because I'm
- 22:32Speaker 6: so charming on the House floor. That was because pharmacists
- 22:35Speaker 6: throughout this country, and Pharmacist United for Truth and Transparency
- 22:39Speaker 6: and APCI and NACP and others reached out to their
- 22:44Speaker 6: legislators and did the work of saying this is important
- 22:47Speaker 6: to me. And I know people are cynical about Members
- 22:51Speaker 6: of Congress and how tuned in they are, but I
- 22:53Speaker 6: will tell you something, when a constituent business owner, when
- 22:57Speaker 6: a constituent resident comes to your office and says that
- 23:01Speaker 6: something matters to you, members of Congress listen. I mean,
- 23:04Speaker 6: we are in the we are in the constituent services business,
- 23:07Speaker 6: and we listen when people say that. And so that
- 23:09Speaker 6: outreach to your local member of Congress absolutely is the
- 23:12Speaker 6: reason we got past fifty.
- 23:14Speaker 1: Now what do we have to do going forward.
- 23:16Speaker 6: Well, one, we're going to reintroduce it, We're going to
- 23:18Speaker 6: build out wider support. But now comes the even harder
- 23:20Speaker 6: part is because we are now going to be up
- 23:24Speaker 6: against a ferocious counter lobbying effort here from PCMA, from
- 23:28Speaker 6: the from the PBM's major lobbying outfit, and maybe even
- 23:31Speaker 6: more impactfully, from the health insurance companies themselves, and they're
- 23:35Speaker 6: going to make one core argument at the end.
- 23:38Speaker 1: Of the day.
- 23:38Speaker 6: I mean they'll do a lot of handwaving and a
- 23:39Speaker 6: lot of bs, but at the end of the day,
- 23:41Speaker 6: when they're meeting with leadership and they're really trying to
- 23:43Speaker 6: kill this thing, they're going to say one thing, and
- 23:45Speaker 6: the one thing they're going to say is this will
- 23:48Speaker 6: raise premiums. No politician wants to be associated with higher
- 23:52Speaker 6: health insurance premiums, and so as a as an entire
- 23:55Speaker 6: coalition of people who want to see a rational pharmaceutical
- 23:59Speaker 6: supply chain, we need to do I think more work
- 24:03Speaker 6: on laying out the evidence for why that is a
- 24:05Speaker 6: scare tactic, for why it will not raise premiums. And
- 24:09Speaker 6: what I have consistently said to Democrats in particular is
- 24:13Speaker 6: this is a fight that we need to pick. If
- 24:15Speaker 6: we don't think as a political party that we can
- 24:17Speaker 6: go in front of the American public and say, you
- 24:20Speaker 6: need health Group made seven billion dollars in profit last quarter,
- 24:24Speaker 6: but they're claiming that if we try to lower your
- 24:26Speaker 6: copays that they have to raise premiums on you. Who
- 24:30Speaker 6: do you trust them or us as a party. If
- 24:32Speaker 6: we really don't think that we can win that fight,
- 24:34Speaker 6: then we should just hang up our.
- 24:36Speaker 1: Cleats, because we're not gonna win.
- 24:37Speaker 6: Elections then like, this is something that we absolutely can
- 24:40Speaker 6: campaign and went on, but we have to have the gumption.
- 24:43Speaker 1: To do it.
- 24:44Speaker 3: Hey, Greg, you mentioned end of year packages. We know
- 24:48Speaker 3: something is already being proposed, it's out. We have even
- 24:52Speaker 3: a stall in getting the budget passed. But this is
- 24:57Speaker 3: all part of it. I know you have other things
- 25:02Speaker 3: that you wanted to share. I want to turn it
- 25:05Speaker 3: over to you.
- 25:06Speaker 5: Yeah, and of course Carn's rockinhas please feel free to
- 25:10Speaker 5: jump in here, right. But there has been has been
- 25:13Speaker 5: talk of, you know, a potential end of your package
- 25:16Speaker 5: where PBM reform could be included. There's been a lot
- 25:19Speaker 5: of talk of maybe some lower cost more transparency which
- 25:22Speaker 5: passed out of the House, which contemplates you know, some
- 25:26Speaker 5: Medicaid managed care reform, which which we like a lot,
- 25:29Speaker 5: as well as some drug pricing transparency, as well as
- 25:32Speaker 5: some packages out of Senate Finance as well MEETPA and
- 25:36Speaker 5: Better which contemplates some delinking concepts as all of some
- 25:40Speaker 5: other things. But you know, one of the things that
- 25:41Speaker 5: I'd like to point out about Pharmacists Fight Back Act
- 25:44Speaker 5: here is you know, this is a bill. It was
- 25:45Speaker 5: introduced to in July of this year, and it has
- 25:50Speaker 5: gotten massive, massive grassroots attention, right. I think I think
- 25:53Speaker 5: a lot of that is that pharmacists, providers, patients have
- 25:56Speaker 5: seen someone who's willing to come out and be a
- 25:59Speaker 5: loud voice in support for change in Congressman Aukin class.
- 26:03Speaker 5: But this is the bill that the PBMs are the
- 26:05Speaker 5: most afraid of, right, This is the bill that the
- 26:07Speaker 5: PBMs are going into offices talking about. This is the
- 26:11Speaker 5: bill that they don't want to see included in the package.
- 26:14Speaker 5: And I would argue that's a mandate on why it
- 26:16Speaker 5: absolutely should be included in a package, whether it's end
- 26:19Speaker 5: of year or whether it's early next year. But make
- 26:22Speaker 5: no mistake, there are pharmacists who've spent weekends writing thousands
- 26:26Speaker 5: of letters right between accumulatively, pharmacists throughout the country. They're
- 26:31Speaker 5: holding up signs for ninety ninety six in their pharmacy,
- 26:34Speaker 5: They've got on their social media sites. I support ninety
- 26:37Speaker 5: ninety six. At the NCPA convention there were ninety ninety
- 26:41Speaker 5: six or die pins. So there has been a true
- 26:43Speaker 5: grassroots movement here on this bill, and this is the
- 26:48Speaker 5: bill that is going to fix a lot of the problems.
- 26:50Speaker 5: And this is why it absolutely should be under the
- 26:53Speaker 5: noses of leadership and should be considered and a material
- 26:57Speaker 5: part of any true PBM reform package. And I'd like
- 27:01Speaker 5: just one more point I'd like to make here is
- 27:05Speaker 5: they're absolutely going to the PBMs and injuriers are going
- 27:07Speaker 5: to say as the sun rises right that premiums are
- 27:10Speaker 5: going to go up and drug prices are going to
- 27:12Speaker 5: go up. And for so long pharmacists have been ringing
- 27:15Speaker 5: the bell, but a lot of what they've been pointing
- 27:17Speaker 5: to has been anecdotal. But we're in a different time
- 27:20Speaker 5: now where we have access to data and we have
- 27:23Speaker 5: really smart people looking at that data, and good data
- 27:26Speaker 5: drives good policy. And whenever we look at the data,
- 27:29Speaker 5: what we see is, hey, surprise, surprise, mail order wasn't
- 27:33Speaker 5: saving money. PBMs, specialty pharmacies weren't saving money.
- 27:36Speaker 1: They were marking up.
- 27:37Speaker 5: One hundred percent, five hundred percent, forty seven thousand percent
- 27:41Speaker 5: on the mail order for everyday generics seventy nine percent
- 27:44Speaker 5: of the time the mail order was higher in a
- 27:46Speaker 5: federal plan three. Access is doing great work, and so
- 27:49Speaker 5: we have to lean into the data to direct and
- 27:52Speaker 5: shape policy and to counter sort of these red herring arguments.
- 27:57Speaker 5: That anything you do to rein in bad PBM practice
- 28:01Speaker 5: is going to somehow raise premiums and or raise cost
- 28:04Speaker 5: at the count.
- 28:05Speaker 3: Representative Achenklass, I just want to say thank you so
- 28:08Speaker 3: much for taking the time to talk with us on
- 28:11Speaker 3: the PBM Reform podcast. I want to give a shout
- 28:13Speaker 3: out to our pharmacy owners. This is important information. Please
- 28:18Speaker 3: use these podcasts, use this interview to talk with your
- 28:23Speaker 3: own state representatives. Send them a link to this podcast
- 28:27Speaker 3: and have them listen to this. This simplifies a very
- 28:30Speaker 3: complex part of healthcare. It's it's probably one of the
- 28:35Speaker 3: most confusing. It's becoming clear. The data is finally rising.
- 28:42Speaker 3: We know that PBMs are not doing what's in the
- 28:47Speaker 3: best interest of healthcare and of public health. Jake, you
- 28:52Speaker 3: know that, Greg, you know that. We all know that. Listeners.
- 28:54Speaker 3: You know that. But your politicians, your government agencies, they
- 29:00Speaker 3: may not understand it. And we're assuming that they don't.
- 29:04Speaker 3: And you, the listener, should assume that your state representative
- 29:09Speaker 3: and your state senators do not understand it. So get
- 29:13Speaker 3: them this podcast episode, Educate them, have them ask lots
- 29:16Speaker 3: of questions of the panel that's being formed. The other legislators.
- 29:22Speaker 3: I just want to say, once again, Jake, thank you
- 29:25Speaker 3: so much for being here with us on the Pharmacy
- 29:28Speaker 3: Podcast Network.
- 29:29Speaker 6: Thank you so much for having me on. I enjoyed
- 29:30Speaker 6: the conversation and happy holidays.
- 29:33Speaker 3: According to a recent news release, the aptly named Patients
- 29:39Speaker 3: Before Monopolies Act was designed to limit the conflict of
- 29:44Speaker 3: interest that are negatively impacting patients in independent pharmacies alike.
- 29:50Speaker 3: Look this up once again. It is the Patients Before
- 29:53Speaker 3: Monopolies Act. This has been a pleasure talking with you. Greg.
- 29:58Speaker 3: Thank you so much for all of your work. We
- 30:00Speaker 3: heard a rumor that you're going to be doing other
- 30:02Speaker 3: things with Pharmacy Podcast Network throughout twenty twenty five. We
- 30:06Speaker 3: cannot wait for you to dig into more of the
- 30:09Speaker 3: PBM Reform podcast content. And Jake, thank you so much
- 30:13Speaker 3: for your services. Thank you for what you're doing for
- 30:16Speaker 3: your state but also our nation. Greg, I'm excited about
- 30:20Speaker 3: twenty twenty five.
- 30:21Speaker 5: Thank you so much. I'm looking forward to it.
- 30:23Speaker 3: For listening to the PBM Reform Podcast, please subscribe on
- 30:28Speaker 3: all of the podcast platforms, whichever one's your favorite, Apple, Spotify, Sprecker.
- 30:34Speaker 3: We wish you a wonderful holiday season. We look forward
- 30:39Speaker 3: to a much more profitable twenty twenty five in the
- 30:44Speaker 3: pharmacy sector. Please reach out to the Pharmacy Podcast Network
- 30:47Speaker 3: if there's anything we can ever do for your state, organizations,
- 30:50Speaker 3: for companies that you work for. You as an individual,
- 30:53Speaker 3: entrepreneurial pharmacist, this is your network of podcasts and we
- 30:58Speaker 3: all are working together to make pharmacy better. And with that,
- 31:02Speaker 3: I thank you for listening to the Pharmacy Podcast Network.